Chia Blog · Clinically reviewed

Evidence-based guides to GLP-1 weight loss.

Long-form explainers on semaglutide and tirzepatide, how to handle side effects, why weight loss plateaus, the science of food noise, and the peptide landscape in 2026 — written with clinicians, edited for patients.

Four injection pens in cream, sage, tan, and charcoal arranged on a warm stone counter with a small sage vase
GLP-1 BasicsFeatured · 9 min read

Ozempic vs. Wegovy vs. Mounjaro vs. Zepbound: The 2026 GLP-1 comparison

Four drugs. Two molecules. Very different use cases. A patient-first comparison of how semaglutide and tirzepatide stack up for weight loss in 2026 — efficacy, side effects, cost, and what the compounded landscape actually looks like now.

Dr. Marcus HollowayApril 12, 2026
Gloved hands labeling a small amber pharmaceutical vial on a warm beige tray with blurred lab glassware in the background
Compounded GLP-110 min read

Compounded GLP-1 in 2026: still legal, still safe? A patient's guide

The FDA declared the semaglutide and tirzepatide shortages over in 2024–2025. Compounding pharmacies did not disappear — the rules changed. Here's what is actually legal, how to tell a real pharmacy from a scam, and the specific questions to ask before your first injection.

Dr. Marcus HollowayApril 9, 2026
Person in soft cream linen holding a glass of water with lemon at a warm-lit kitchen counter with a sage ceramic bowl
Side Effects11 min read

GLP-1 side effects decoded: what's normal, what's not, and how to manage them

Nausea, constipation, reflux, the "sulfur burps" — almost every GLP-1 side effect is predictable, temporary, and manageable. A practical, clinician-written playbook for getting through the first 8 weeks without quitting your medication.

Dr. Marcus HollowayApril 6, 2026
A stepping stone path winding through soft-focus sage foliage at golden hour, metaphor for gradual progress
Results & Plateaus10 min read

The GLP-1 plateau: why the scale stalls and how to restart progress

Around month 4–6, most GLP-1 patients hit a plateau. The medication is still working — your body is recalibrating. Here is what is actually happening, how to tell a plateau from a stall, and the five evidence-based levers that restart loss without abandoning your protocol.

Dr. Marcus HollowayApril 4, 2026
A half-eaten apple on a warm-wood cutting board at a quiet kitchen counter at first light
Science8 min read

Food noise: how GLP-1 drugs actually rewire hunger

"Food noise" started as a patient phrase and became a research-grade concept in three years flat. Here is what it really is, how semaglutide and tirzepatide silence it, and what happens when you stop the medication.

Dr. Marcus HollowayApril 1, 2026
Abstract sage-green and gold translucent sculptural ribbon suggesting a peptide chain, soft backlit
Peptides9 min read

Peptide therapy in 2026 (beyond GLP-1): an educated patient's guide

You're on a GLP-1, Instagram keeps serving you BPC-157 ads, and you have questions. Here is the honest landscape — what peptides are actually FDA-approved, what is legally compoundable, what to avoid, and how to tell science from influencer marketing.

Dr. Marcus HollowayMarch 28, 2026

Ready when you are

Curious if GLP-1 is right for you?

Take our 3-minute clinical quiz. You'll get a personalized plan reviewed by a US-licensed clinician — no commitment.

Take the 3-min quiz